Palisade Bio (PALI) Other Non Operating Income (2014 - 2026)

Palisade Bio (PALI) has reported Other Non Operating Income for 13 consecutive years, with $1.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non Operating Income rose 1318.52% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $2.4 million (up 541.14% YoY), while the FY2025 annual figure was $1.3 million, up 196.77% from the prior year.
• Other Non Operating Income grew to $1.1 million in Q1 2026 per PALI's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Non Operating Income topped out at $1.2 million in Q2 2022 and bottomed at $41000.0 in Q4 2024.
• Historically, Other Non Operating Income has averaged $366823.5 across 5 years, with a median of $187000.0 in 2023.
• Annual changes were most pronounced in 2022 — Other Non Operating Income slumped 99.42% — and 2025, when it jumped 2543.9%.
• Palisade Bio's Other Non Operating Income stood at $131000.0 in 2022, then soared by 42.75% to $187000.0 in 2023, then plunged by 78.07% to $41000.0 in 2024, then surged by 2543.9% to $1.1 million in 2025, then grew by 6.0% to $1.1 million in 2026.
• Business Quant data shows PALI's Other Non Operating Income at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $59000.0 in Q3 2025.